FemTech & Pregnancy Apps

The FDA has approved Pfizer‘s IBRANCE (palbociclib) in combination with trastuzumab, with or without pertuzumab, and endocrine therapy for the

THE UK GOVERNMENT has set out details of announcements on leveraging AI, spanning investment and workforce transformation, at London Tech

By Jane Lewis, chief operating officer, chief financial officer and women’s health lead, ABHI For years, the conversation around women’s

Image: Conceivable IVI RMA Global, a leading fertility care organization, and Conceivable Life Sciences have announced a strategic partnership –